Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Orhub Inc (OP: ORHB )

0.0720 UNCHANGED
Streaming Delayed Price Updated: 3:18 PM EDT, Jun 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0720
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0720
Today's Range 0.0720 - 0.0720
52wk Range 0.0400 - 0.2000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PUR Biologics Begins Shipment of its Breakthrough Product PURbonedough(TM)
Via ACCESSWIRE
PUR Biologics Expands Sales Network by 15%, Adding 32 New Distributors
Via ACCESSWIRE

Performance

YTD
-57.65%
-57.65%
1 Month
-27.27%
-27.27%
3 Month
-40.00%
-40.00%
6 Month
-33.94%
-33.94%
1 Year
-6.49%
-6.49%

More News

Read More
CORRECTION BY SOURCE: Goldman Small Cap Research Publishes New Research Report on HippoFi, Inc.
Via ACCESSWIRE
Goldman Small Cap Research Publishes New Research Report on HippoFi, Inc.
Via ACCESSWIRE
US Patent Office Grants PUR Biologics' Breakthrough Patent for Activating Immune Cells
Via ACCESSWIRE
PUR Biologics Launches PURfiberXP(TM), a Best-in-Class Cortical Fiber Matrix for Bone Regeneration
Via ACCESSWIRE
HippoFi Begins 2023 with Strong Sales of Advanced Biomaterials
Via ACCESSWIRE
HippoFi’s Regenerative Therapeutics Division, Launches PURbridge(TM) for Spine Surgery
Via ACCESSWIRE
HippoFi Signs Strategic Partnership Agreement with Precision Spine, Inc.
Via ACCESSWIRE
HippoFi Announces Its Return to a Pink Current Information Tier on the OTC Market
Via ACCESSWIRE
PUR Biologics Announces Launch of PURcore, a bioActive Moldable Synthetic for Spine Surgery
Via ACCESSWIRE
Company Update from Executive Chairman & CEO
Via ACCESSWIRE
ORHub Adopts New Name to Reflect Its Fintech Future - "HippoFi"
Via ACCESSWIRE
ORHub's PUR Biologics to Launch PUR Pillars
From ORHUB, Inc.
Via AccessWire
ORHub's PUR Biologics to Launch PUR Pillars
Via ACCESSWIRE
Orhub’s Ryan Fernan Becomes Head Of Pur Biologics, Leading Regenerative Therapeutic Efforts
From ORHUB, Inc.
Via AccessWire
Exposures Product Safety
Orhub’s Ryan Fernan Becomes Head Of Pur Biologics, Leading Regenerative Therapeutic Efforts
Via ACCESSWIRE
Healthcare Innovator "ORHub" Aims to Enter the Fintech Industry
Via ACCESSWIRE
Healthcare Innovator "ORHub" Aims to Enter the Fintech Industry
From ORHUB, Inc.
Via AccessWire
Exposures Product Safety
ORHub Retains Predica to Launch New Software Platform
From ORHUB, Inc.
Via AccessWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
ORHub Acquires PUR Biologics, Entering the Global Medical Device Market
From ORHUB, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
ORHub Prepares To Finalize Acquisition Of Pur Biologics
From ORHUB, Inc.
Via AccessWire
ORHub, Inc. the Courts Rule To "Dismiss With Prejudice" the Lawsuit Brought by Frederic J. Buonincontri & Axt Analytics, LLC
From ORHub, Inc.
Via AccessWire
Topics Lawsuit
Exposures Financial Legal
Orhub's Story Proves the Power of a Winning Culture
From ORHUB, Inc.
Via AccessWire
ORHub Executes Letter Of Intent For Acquisition
From ORHUB, Inc.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.